Majority Leader Frist jumps ship on stem-cell research, and a decision on OTC status for Plan B is imminent—maybe
With Labor Day celebrations completed, Congress reassembled in the Capitol, ready to tackle what remains unresolved of President George W. Bush's 2005 agenda. Now is the time for the Senate Judiciary Committee to grill Supreme Court nominee John G. Roberts on his qualifications for the highest court in the land, and for the Food and Drug Administration (FDA) to make good on a promise to rule on the over-the-counter (OTC) status of Plan B (levonorgestrel), the emergency contraceptive pill. During the congressional recess last month, the president signed into law energy and transportation bills-major legislation stuffed with goodies to placate partisans of all political persuasions.
Pediatric cancer survivors and cardiovascular toxicity, disease risk
March 21st 2025Pediatric cancer survivors can be vulnerable to cardiovascular disease in the short- or long-term with increased recognition of cardiotoxic cancer treatments, as 5-year survival rates for children are greater than 85%.